Furthermore, by modulating the expression levels of STT3B and DDOST, the impact of N‐glycosylation modification at residue 263 of CTSD on the biological behaviors of CRC cells can be replicated in vitro. The gene discussed is STT3B; the disease is colorectal carcinoma.